Humeral Head Implants: Radiological and Clinical Evaluation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 40 to 85 years at time of surgery
- Patients with primary or secondary osteoarthritis of the shoulder
Exclusion Criteria:
- Patients with cuff tear arthropathy and axillary nerve lesions
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Total shoulder arthroplasty (TSA)
Replacement of humeral head and glenoid
|
stemless humeral head implant: Eclipse™ (Arthrex Inc., Naples, FL, USA)
stemless humeral head implant
|
|
Hemi shoulder arthroplasty (HSA)
Replacement of humeral head only
|
stemless humeral head implant
stemless humeral head implant: Eclipse™ (Arthrex Inc., Naples, FL, USA)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the Constant score
Time Frame: 5 years
|
The Constant score is a validated outcome score assessing pain and function of the shoulder
|
5 years
|
|
Radiological assessment to determine radiolucent areas and osteolysis around the humeral head
Time Frame: 5 years
|
5 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the Constant score
Time Frame: Change from baseline to 2 years postimplantation
|
Change from baseline to 2 years postimplantation
|
|
Radiological assessment to determine radiolucent areas and osteolysis around the humeral head
Time Frame: 2 years
|
2 years
|
|
the Constant score
Time Frame: Change from baseline to 5 years postimplantation
|
Change from baseline to 5 years postimplantation
|
|
the Constant score
Time Frame: 10 years
|
10 years
|
|
Radiological assessment to determine radiolucent areas and osteolysis around the humeral head
Time Frame: 10 years
|
10 years
|
|
the Constant score
Time Frame: 15-20 years
|
15-20 years
|
|
Radiological assessment to determine radiolucent areas and osteolysis around the humeral head
Time Frame: 15-20 years
|
15-20 years
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HHI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.